Home/DAMONA Pharmaceuticals/Rob Risinger, MD

RR

Rob Risinger, MD

Consulting Chief Medical Officer

DAMONA Pharmaceuticals

Therapeutic Areas

Neurodegenerative diseases Psychiatric disorders Cognitive impairment

DAMONA Pharmaceuticals Pipeline

Drug	Indication	Phase
DPX-101	Cognitive deficits in Alzheimer’s disease and other CNS disorders	Phase 1

Leadership Team at DAMONA Pharmaceuticals

Chief Executive Officer

Etienne Sibille, PhD

Scientific Founder

View full DAMONA Pharmaceuticals profile